Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, London WC1E 7HX, UK.
Front Biosci (Landmark Ed). 2012 Jan 1;17(5):1861-81. doi: 10.2741/4024.
Mycobacteria are a group of aerobic, non-motile, acid fast bacteria that have a characteristic cell wall composed of a mycolyl-arabinogalactan-peptidoglycan complex. They display different phenotypic attributes in their growth, color and biochemistry. Tuberculosis (TB) is defined as the infection with Mycobacterium tuberculosis complex and was declared a global health emergency principally because of the appearance of multidrug-resistant strains and the associated risk of infection in immune-compromised population. There is an urgent clinical need for novel, potent and safe anti-TB drugs. Natural products have been used since antiquity for treating diverse complaints and novel pharmacophores are discovered every year. Two of the most potent used antimycobacterials, the rifamycins and streptomycin, were first detected in Streptomyces bacteria. Plants are also the source of an exquisite variety of antimicrobials that can lead to useful therapeutics in the future. In this review, natural preparations used since antiquity for treating tuberculosis are described, together with a rapid view of the 20th century antibiotic development against TB. Finally a summary of the most potent recent natural antimycobacterials is displayed.
分枝杆菌是一组需氧、非运动、抗酸的细菌,其细胞壁具有特征性,由 mycolyl-arabinogalactan-peptidoglycan 复合物组成。它们在生长、颜色和生物化学方面表现出不同的表型特征。结核病 (TB) 定义为感染结核分枝杆菌复合体,主要由于多药耐药株的出现以及免疫功能低下人群的感染风险而被宣布为全球卫生紧急情况。迫切需要新型、有效和安全的抗结核药物。天然产物自古以来就被用于治疗各种疾病,每年都有新的药效团被发现。两种最有效的抗分枝杆菌药物,利福平和链霉素,最初是在链霉菌中检测到的。植物也是各种抗菌剂的来源,这些抗菌剂将来可能成为有用的治疗药物。在这篇综述中,描述了自古以来用于治疗结核病的天然制剂,并快速回顾了 20 世纪针对结核病的抗生素开发。最后,展示了最近最有效的天然抗分枝杆菌药物的摘要。